RESEARCH TRIANGLE PARK, N.C., March 31, 2014 (GLOBE NEWSWIRE) -- NephroGenex, Inc. (Nasdaq:NRX), a pharmaceutical company focused on the development of therapeutics to treat kidney disease, today reported financial results for the year ended December 31, 2013, and provided an update on the Company's progress and plans.
Help employers find you! Check out all the jobs and post your resume.
